Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1929 1
1937 1
1940 1
1941 1
1945 3
1946 1
1947 4
1948 4
1950 4
1951 3
1952 4
1953 3
1954 3
1955 3
1956 1
1957 2
1958 2
1959 4
1960 3
1961 4
1962 2
1963 4
1964 11
1965 4
1966 2
1967 3
1968 1
1969 2
1970 8
1971 2
1972 6
1973 1
1974 6
1975 3
1976 3
1977 2
1978 4
1979 4
1980 4
1981 3
1982 2
1983 5
1984 8
1985 5
1986 6
1987 10
1988 8
1989 11
1990 4
1991 7
1992 8
1993 11
1994 17
1995 12
1996 15
1997 26
1998 22
1999 23
2000 21
2001 16
2002 16
2003 13
2004 23
2005 21
2006 34
2007 32
2008 38
2009 34
2010 44
2011 44
2012 33
2013 44
2014 33
2015 32
2016 24
2017 36
2018 28
2019 27
2020 32
2021 33
2022 29
2023 23
2024 31
2025 20

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

994 results

Results by year

Filters applied: . Clear all
Page 1
Toxic Alcohol Poisoning.
Ross JA, Borek HA, Holstege CP, King JD. Ross JA, et al. Emerg Med Clin North Am. 2022 May;40(2):327-341. doi: 10.1016/j.emc.2022.01.012. Epub 2022 Apr 5. Emerg Med Clin North Am. 2022. PMID: 35461626 Review.
Pediatric Toxicology.
Ross JA, Eldridge DL. Ross JA, et al. Emerg Med Clin North Am. 2022 May;40(2):237-250. doi: 10.1016/j.emc.2022.01.004. Epub 2022 Apr 5. Emerg Med Clin North Am. 2022. PMID: 35461621 Review.
Toxic Alcohols.
Ross JA, Borek HA, Holstege CP. Ross JA, et al. Crit Care Clin. 2021 Jul;37(3):643-656. doi: 10.1016/j.ccc.2021.03.009. Crit Care Clin. 2021. PMID: 34053711 Review.
Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.
Pullarkat VA, Lacayo NJ, Jabbour E, Rubnitz JE, Bajel A, Laetsch TW, Leonard J, Colace SI, Khaw SL, Fleming SA, Mattison RJ, Norris R, Opferman JT, Roberts KG, Zhao Y, Qu C, Badawi M, Schmidt M, Tong B, Pesko JC, Sun Y, Ross JA, Vishwamitra D, Rosenwinkel L, Kim SY, Jacobson A, Mullighan CG, Alexander TB, Stock W. Pullarkat VA, et al. Among authors: ross ja. Cancer Discov. 2021 Jun;11(6):1440-1453. doi: 10.1158/2159-8290.CD-20-1465. Epub 2021 Feb 16. Cancer Discov. 2021. PMID: 33593877 Free PMC article. Clinical Trial.
Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial.
Kumar SK, Harrison SJ, Cavo M, de la Rubia J, Popat R, Gasparetto C, Hungria V, Salwender H, Suzuki K, Kim I, Punnoose EA, Hong WJ, Freise KJ, Yang X, Sood A, Jalaluddin M, Ross JA, Ward JE, Maciag PC, Moreau P. Kumar SK, et al. Among authors: ross ja. Lancet Oncol. 2020 Dec;21(12):1630-1642. doi: 10.1016/S1470-2045(20)30525-8. Epub 2020 Oct 29. Lancet Oncol. 2020. PMID: 33129376 Clinical Trial.
EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma.
Landgren O, Prior TJ, Masterson T, Heuck C, Bueno OF, Dash AB, Einsele H, Goldschmidt H, Knop S, Li C, Mellqvist UH, McFadden I, Oprea C, Ross JA, Talpes M, Hydren JR, Ahlstrom JM, Kazandjian D, Weinhold N, Zhang R, Stetler-Stevenson M, Marti G, Devlin SM. Landgren O, et al. Among authors: ross ja. Blood. 2024 Jul 25;144(4):359-367. doi: 10.1182/blood.2024024371. Blood. 2024. PMID: 38768337 Free PMC article.
A Phase I First-in-Human Study of ABBV-383, a B-Cell Maturation Antigen × CD3 Bispecific T-Cell Redirecting Antibody, in Patients With Relapsed/Refractory Multiple Myeloma.
D'Souza A, Shah N, Rodriguez C, Voorhees PM, Weisel K, Bueno OF, Pothacamury RK, Freise KJ, Yue S, Ross JA, Polepally AR, Talati C, Lee S, Jin Z, Buelow B, Vij R, Kumar S. D'Souza A, et al. Among authors: ross ja. J Clin Oncol. 2022 Nov 1;40(31):3576-3586. doi: 10.1200/JCO.22.01504. Epub 2022 Aug 27. J Clin Oncol. 2022. PMID: 36029527 Free PMC article. Clinical Trial.
A Blessing.
Ross JA. Ross JA. Tex Heart Inst J. 2017 Oct 1;44(5):301. doi: 10.14503/THIJ-17-6482. eCollection 2017 Oct. Tex Heart Inst J. 2017. PMID: 29259497 Free PMC article. No abstract available.
Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia.
Place AE, Karol SE, Forlenza CJ, Cooper TM, Fraser C, Cario G, O'Brien MM, Gerber NU, Bourquin JP, Reinhardt D, Rubnitz JE, Opferman JT, Sunkersett G, Onishi M, Dunshee DR, Chen X, Unnebrink K, Vishwamitra D, Dunbar F, Badawi M, Ross JA, Loh ML. Place AE, et al. Among authors: ross ja. Pediatr Blood Cancer. 2025 Jun;72(6):e31630. doi: 10.1002/pbc.31630. Epub 2025 Mar 10. Pediatr Blood Cancer. 2025. PMID: 40062648 Clinical Trial.
994 results